Profile data is unavailable for this security.
About the company
Natac Natural Ingredients SA, formerly IFFE Futura SA, is a Spain-based company dedicated to the research, development and production of natural extracts. The Company operates through two main business segments: Plant Extracts, which focuses on the development and production of natural extracts derived from various plants; and Omega 3, which is dedicated to the production of Omega 3 fatty acids, which are essential nutrients used in dietary supplements and functional foods to support cardiovascular health and other health benefits. The Company has a presence in both national and international markets, offering natural ingredients for the pharmaceutical, nutraceutical, animal feed, pet nutrition, food, and cosmetics industries.
- Revenue in EUR (TTM)32.61m
- Net income in EUR-5.87m
- Incorporated2011
- Employees184.00
- LocationNatac Natural Ingredients SAavenida Rita Levi Montalcini n 14GETAFE 28906SpainESP
- Phone+34 881896049
- Websitehttps://natacgroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Nucien Pharmaceutical Co Ltd | 14.63m | -43.18m | 284.38m | 360.00 | -- | 2.69 | -- | 19.44 | -1.28 | -1.28 | 0.4362 | 3.16 | 0.0998 | 1.41 | 0.4888 | -- | -32.50 | -5.94 | -36.98 | -8.19 | 32.41 | 83.51 | -325.67 | -15.02 | 2.29 | -139.49 | 0.1562 | -- | -64.64 | -23.64 | -9,613.65 | -- | 35.48 | -- |
| Puma Biotechnology Inc | 178.59m | 31.15m | 288.66m | 172.00 | 9.17 | 2.97 | 7.12 | 1.62 | 0.7414 | 0.7414 | 4.23 | 2.29 | 1.00 | 8.06 | 4.81 | 1,232,529.00 | 17.46 | -3.25 | 32.09 | -5.70 | 76.91 | 75.67 | 17.44 | -3.18 | 1.62 | 8.84 | 0.2263 | -- | -2.19 | -3.28 | 40.23 | -- | -28.80 | -- |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 62.65m | -22.44m | 289.69m | 906.00 | -- | 3.27 | -- | 4.62 | -1.84 | -1.84 | 5.14 | 7.26 | 0.2636 | 1.93 | 2.53 | 566,479.70 | -11.36 | -1.99 | -18.19 | -2.69 | 24.46 | 36.16 | -43.08 | -6.59 | 0.5483 | -2.10 | 0.4726 | -- | -16.54 | 5.42 | -242.62 | -- | -10.54 | -- |
| Standard Chem & Pharm Co Ltd | 185.33m | 23.95m | 290.89m | 1.13k | 12.16 | 1.82 | 6.56 | 1.57 | 4.99 | 4.99 | 38.63 | 33.29 | 0.6066 | 2.48 | 5.98 | -- | 10.80 | 10.48 | 19.18 | 19.42 | 42.14 | 43.86 | 17.81 | 18.24 | 1.69 | -- | 0.1034 | 58.43 | 8.81 | 11.51 | 5.46 | 18.52 | 27.42 | 13.30 |
| Natac Natural Ingredients SA | 32.61m | -5.87m | 291.34m | 184.00 | -- | 7.55 | 271.53 | 8.93 | -0.0136 | -0.0136 | 0.0755 | 0.0887 | 0.2389 | 0.0504 | 4.21 | 198,840.70 | -4.30 | 1.15 | -6.32 | 1.42 | 97.29 | -- | -18.00 | 6.49 | 0.2161 | -0.2629 | 0.6672 | -- | 35.01 | 91.00 | -93.80 | 3.85 | 563.61 | -- |
| Gufic BioSciences Ltd | 81.26m | 5.29m | 291.65m | 1.99k | 55.06 | 4.97 | 36.95 | 3.59 | 5.68 | 5.68 | 87.10 | 62.94 | 0.7354 | 1.87 | 2.75 | 4,394,322.00 | 4.79 | 10.27 | 7.34 | 16.11 | 55.47 | 46.41 | 6.52 | 10.48 | 1.06 | 3.13 | 0.3691 | 1.31 | 1.63 | 16.69 | -19.14 | 25.15 | 13.64 | 14.87 |
| Duopharma Biotech Bhd | 194.43m | 18.02m | 294.86m | 1.96k | 16.36 | 1.84 | 10.59 | 1.52 | 0.0868 | 0.0868 | 0.9363 | 0.7736 | 0.6425 | 2.17 | 3.96 | 460,233.50 | 5.96 | 5.22 | 7.21 | 6.30 | 38.04 | 39.04 | 9.27 | 9.04 | 1.62 | 6.65 | 0.3975 | 44.97 | 15.46 | 7.14 | 19.00 | 2.54 | -11.06 | -2.33 |
| Jiangsu gdk Biotechnology Co Ltd | 14.23m | -15.44m | 297.92m | 452.00 | -- | 2.05 | -- | 20.94 | -1.03 | -1.03 | 0.9461 | 9.67 | 0.0775 | 0.7322 | 1.14 | 257,878.40 | -8.42 | 1.65 | -9.84 | 2.14 | 60.80 | 73.17 | -108.54 | 7.56 | 1.83 | -- | 0.0465 | 53.80 | -39.96 | 3.77 | -31.71 | -- | 12.74 | -- |
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 30.71m | 4.05m | 298.95m | 362.00 | 73.86 | 36.78 | -- | 9.74 | 0.2723 | 0.2723 | 2.07 | 0.5468 | 0.632 | 2.97 | 2.32 | 694,905.80 | 8.32 | -8.84 | 27.42 | -25.80 | 47.93 | 32.17 | 13.17 | -21.83 | 0.655 | 9.23 | 0.648 | -- | 78.44 | -6.06 | 139.83 | -21.36 | -26.32 | -- |
| Celon Pharma SA | 54.26m | -28.99m | 299.82m | 566.00 | -- | 3.25 | -- | 5.53 | -2.21 | -2.21 | 4.21 | 7.23 | 0.4192 | 2.82 | 4.69 | 409,607.50 | -22.40 | -3.79 | -25.34 | -4.45 | 68.73 | 69.91 | -53.43 | -11.70 | 1.47 | -- | 0.0352 | -- | -4.33 | 15.17 | -22.48 | -- | -18.90 | -- |
Data as of Feb 13 2026. Currency figures normalised to Natac Natural Ingredients SA's reporting currency: Euro EUR
0.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Andbank Wealth Management SGIIC SAUas of 04 Feb 2026 | 965.00k | 0.22% |
| Renta 4 Gestora SGIIC SAas of 31 Dec 2025 | 625.92k | 0.14% |
Data from 31 Dec 2025 - 04 Feb 2026Source: FactSet Research Systems Inc.
